Literature DB >> 33680928

Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review.

Biyuan Xing1, Jianfeng Guo2, Yuhan Sheng1, Gang Wu1, Yingchao Zhao1.   

Abstract

Human papillomavirus (HPV) has been the leading cause of cervical cancer for over 25 years. Approximately 5.5-11% of all cervical cancers are reported to be HPV-negative, which can be attributed to truly negative and false-negative results. The truly HPV-negative cervical cancers are almost all cervical adenocarcinomas with unclear etiology. False HPV negativity can arise from histological misclassification, latent HPV infection, disruption of the targeting fragment, non-high risk HPV infection, and HPV testing methods. HPV-negative cervical cancers are often diagnosed at an advanced FIGO stage and have a poor prognosis; thus, the management of these cases requires greater attention.
Copyright © 2021 Xing, Guo, Sheng, Wu and Zhao.

Entities:  

Keywords:  cervical cancer; false-negative; human papillomavirus; human papillomavirus (HPV) testing; human papillomavirus (HPV)-negative

Year:  2021        PMID: 33680928      PMCID: PMC7925842          DOI: 10.3389/fonc.2020.606335

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  14 in total

1.  Human papillomavirus targets the YAP1-LATS2 feedback loop to drive cervical cancer development.

Authors:  Cong Huang; Xiangmin Lv; Peichao Chen; Jiyuan Liu; Chunbo He; Li Chen; Hongbo Wang; Madelyn L Moness; Jixin Dong; Bo R Rueda; John S Davis; Cheng Wang
Journal:  Oncogene       Date:  2022-06-27       Impact factor: 8.756

2.  Investigation of multiple Felis catus papillomavirus types (-1/-2/-3/-4/-5/-6) DNAs in feline oral squamous cell carcinoma: a multicentric study.

Authors:  Gennaro Altamura; Bianca Cuccaro; Claudia Eleni; Carina Strohmayer; Sabine Brandt; Giuseppe Borzacchiello
Journal:  J Vet Med Sci       Date:  2022-04-15       Impact factor: 1.105

3.  Mutation Analysis of Radioresistant Early-Stage Cervical Cancer.

Authors:  Tae Oike; Yoshihito Sekiguchi; Yuya Yoshimoto; Takahiro Oike; Ken Ando; Wenchao Gu; Yasushi Sasaki; Takashi Tokino; Akira Iwase; Tatsuya Ohno
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

4.  Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes.

Authors:  Xiaojun Zhu; Shengwei Li; Jiangti Luo; Xia Ying; Zhi Li; Yuanhe Wang; Mengmeng Zhang; Tianfang Zhang; Peiyue Jiang; Xiaosheng Wang
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

5.  Screening Plasma Exosomal RNAs as Diagnostic Markers for Cervical Cancer: An Analysis of Patients Who Underwent Primary Chemoradiotherapy.

Authors:  Oyeon Cho; Do-Wan Kim; Jae-Youn Cheong
Journal:  Biomolecules       Date:  2021-11-14

6.  The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis.

Authors:  Mikhail Salnikov; Steven F Gameiro; Peter Y F Zeng; John W Barrett; Anthony C Nichols; Joe S Mymryk
Journal:  mSphere       Date:  2022-08-11       Impact factor: 5.029

7.  Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer.

Authors:  Yanyun Ma; Chunxia Wang; Mengqi Shi; Mingshan Li; Lin Li; Tuanjie Che; Jing Qu
Journal:  Mol Clin Oncol       Date:  2022-09-02

8.  HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct.

Authors:  Andris M Evans; Mikhail Salnikov; Steven F Gameiro; Saman Maleki Vareki; Joe S Mymryk
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

Review 9.  Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers.

Authors:  Hiroshi Yoshida; Kouya Shiraishi; Tomoyasu Kato
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

10.  Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report.

Authors:  Mateja Sladič; Pepita Taneska; Branko Cvjetičanin; Mojca Velikonja; Vladimir Smrkolj; Špela Smrkolj
Journal:  Medicina (Kaunas)       Date:  2022-02-23       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.